, which may increase dissemination between its many vertebrate hosts (FIG. 1) . Humans do not typically transmit the parasite, but they readily become infected by ingesting sporozoites in water or tissue cysts in undercooked meat 4, 5 . The clinical signs of infection in humans range from mild flu-like symptoms in most people to severe complications in immunocompromised individuals or following transplacental transmission to a fetus 6 . This range of clinical severity is probably a consequence of many factors, including host and parasite geno types, and associations between these genotypes have been noted in ocular disease 7 , congenital infection 8, 9 and in patients with AIDS 10 . Although most infections do not lead to serious complications, toxoplasmosis is the third leading cause of food-borne infections requiring hospitalization in the United States 11 . Within its vertebrate host, T. gondii encounters many challenges in crossing biological barriers, avoiding immune surveillance and establishing its niche as an intracellular parasite. This journey begins in the gut, where parasites invade enterocytes and replicate, but they can also cross the epithelial barrier and reach the lamina propria, where they encounter resident macrophages, dendritic cells (DCs) and intraepithelial lymphocytes 12 .
The infection spreads rapidly to draining lymph nodes, the spleen and eventually all organs. T. gondii is equipped with an efficient system for motility that underlies its ability to invade cells and disseminate in the host 13, 14 (BOX 1). When established in the host cell, T. gondii resides in a unique parasitophorous vacuole (PV) that does not fuse with the endolysosomal system 15 . Because tachyzoites can infect any cell type and tissue, and replication leads to cell lysis, the parasite has a tremendous potential to cause disease. The innate immune response limits parasite growth and promotes the development of adaptive immunity, which is required for long-term resistance to infection 16 . The immune response also induces differentiation of the parasite into its chronic semidormant form (bradyzoites), potentially averting Protozoans of the phylum Apicomplexa that are known for their apical complex consisting of a specialized microtubule-organizing centre, called the conoid, and secretory organelles involved in host cell invasion. Toxoplasma spp. belong to the tissue cyst-forming coccidian group of apicomplexans.
Oocysts
The diploid stages of parasite development, resulting from the fusion of Toxoplasma gondii gametes. Oocysts are shed in cat faeces and thus contaminate the environment, giving rise to infection by accidental ingestion.
Bradyzoites
The slow-growing forms of certain parasites; these forms reside within long-lived tissue cysts that are associated with chronic infection. The bradyzoite is one of the parasite stages that is specialized for transmission if ingested. The name is derived from the Greek bradys, meaning slow. a lethal showdown between the pathogen and its host. However, the immune response is unable to eradicate the tissue cysts, and reactivation of the cysts can cause severe disease in patients with primary or acquired defects in T cell-mediated immunity 17 .
In addition to its importance in public health, T. gondii has emerged as a model organism for studying the molecular basis of pathogenesis in related apicomplexans. These related parasites include the human pathogens Plasmodium and Cryptosporidium spp., as well as parasites of livestock such as Eimeria and Neospora spp. T. gondii is a convenient model system owing to its ease of use, the existence of excellent mouse models and the availability of an abundance of genetic tools 18, 19 . In recent years, advances in our understanding of innate immunity, combined with the development of forward-genetics systems in the parasite, have provided new insights into the novel mechanisms that T. gondii uses to survive in the host. The emerging picture reveals that the organism has evolved an intricate system of virulence factors that counteract the host innate immune response. The aim of this Review is to highlight these recent studies and to provide a framework for future studies aiming to delineate the molecular events that determine the outcome of infection. . The fusion of gametes leads to the formation of diploid oocysts that are shed in cat faeces and undergo meiosis in the environment to yield eight haploid progeny sporozoites. In the intermediate host (shown here as rodents), asexual replication occurs. Acute infection is characterized by tachyzoites (rapidly replicating forms) that disseminate throughout the body. Differentiation to slow-growing bradyzoites within tissue cysts leads to long-term chronic infection. Ingestion of tissue cysts via omnivorous or carnivorous feeding can lead to transmission to either other intermediate hosts or to cats, re-initiating the sexual phase of the life cycle. Oocysts are capable of surviving in the environment for long periods of time, and sporulated oocysts (which are infectious) can contaminate food and water, providing a route of infection for intermediate hosts. Many animals serve as intermediate hosts, including farm animals. Humans become infected by eating undercooked meat containing tissue cysts or by ingesting sporulated oocysts in contaminated water 4, 5 . Although most human infections are mild, toxoplasmosis can cause serious symptoms in the brain and other organs (as indicated) in immunocompromised patients, as well as in the developing fetus following congenital infection. 
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Natural genetic variants of T. gondii
Despite members of the genus Toxoplasma having a broad host range, comprising many orders of mammals and birds, the genus contains a single species, T. gondii, named after the African rodent (Ctenodactylus gundi) from which it was first isolated in the early 1900s 20 . Populations of T. gondii in North America and Europe are dominated by three clonal lineages known as types I, II and III 21 . The three clonal lineages show evidence of having been derived from a few genetic crosses among closely related parents 22 and, following this recent genetic bottleneck, have undergone rapid expansion 3 . The majority of infections in humans in North America and Europe are caused by type II strains, which probably reflects the abundance of these strains in livestock 23 . In marked contrast to this, the popu lation structure of T. gondii in South America is more diverse, suggesting that there is a higher frequency of sexual recombination in this area 23 . Recent studies based on a larger collection of isolates from around the world that display wider genetic diversity have revealed more than 15 lineages that fall into six major groups 24 . For the purposes of this Review, we focus on the more widely studied type I, type II and type III lineages, which each use different strategies to induce and/or disrupt the host immune response and thereby assure their survival and transmission.
Rodents are natural hosts for T. gondii, and laboratory mice therefore provide a reasonable model to study the immunological events involved in the control of T. gondii infection 25 . In laboratory mice, type I strains are uniformly lethal with an infectious dose of a single viable organism 26 , whereas type II strains have an intermediate virulence that varies with mouse strain, and type III para sites are considered avirulent 26 . Other phenotypes that differ between the three major lineages include intrinsic growth rate 27 , frequency of differentiation, motility, the potential to cross biological barriers 28 , disruption of host cell signalling (see below), induction of intestinal pathology during acute infection 29 and develop ment of central nervous system pathology during chronic infection in the mouse 30 .
The innate immune response to T. gondii For more than 60 years, T. gondii has been an important model organism for understanding how the murine immune system promotes resistance to intracellular pathogens 16 . Most laboratory studies have used type II strains (of intermediate virulence), which has facilitated the study of the immune response in mice during the acute and chronic phases of infection. These in vivo studies, combined with analyses of mice lacking various immune effector genes, have defined important components of innate resistance (see Supplementary information S1 (table)) . Collectively, these studies have revealed that control of T. gondii requires early production of the pro-inflammatory cytokine interleukin-12 (IL-12), which stimulates natural killer (NK) cells and CD4 + and CD8 + T cells to release interferon-γ (IFNγ) [31] [32] [33] [34] (FIG. 2) .
Although lysis of parasite-infected cells by these cytotoxic lymphocytes contributes to resistance, the primary role of these immune cells is the production of IFNγ, which upregulates antimicrobial effector mechanisms to control T. gondii 35 . The importance of IL-12 induction in early infection is evident from studies reporting that monocytes 36 , CD8α + DCs 37, 38 , plasmacytoid DCs 39, 40 and neutrophils 41 all contribute to the production of this activation signal (FIG. 2) . Selective-ablation studies have implicated CD8α
+ DCs 38 and inflammatory monocytes 42 as early sources of IL-12 in vivo, and consistent with this, the recruitment of inflammatory monocytes to the site of infection is essential to control parasite growth 43, 44 . In addition, MYD88 -a central adaptor protein required for the function of multiple Toll-like receptors (TLRs) and several cytokines -is essential for controlling infection 45 (see Supplementary information S1 (table) ). There has also been progress in defining the parasite molecules and host receptors involved in initial recognition of the parasite, including TLR2-and TLR4-mediated detection
Box 1 | Toxoplasma gondii invasion and dissemination in the host
Host cell invasion by Toxoplasma gondii involves the concerted action of protein secretion along with actin-based motility 13, 14 (see the figure) . An initial wave of secretion from micronemes is required for motility and host cell attachment 138 . During invasion, the parasite invaginates the plasma membrane of the host cell to create a uniquely modified compartment called the parasitophorous vacuole (PV) 15 . PV formation is initiated by secretion from a bulb-shaped parasite organelle called the rhoptry, which contains a diverse array of proteins 139 that are released directly into the host cell and into the forming vacuole 89 . Proteins in the rhoptry neck (RONs) are initially secreted into the host cell membrane, where they help mediate the formation of a moving junction composed of RON2, RON4 and RON5 together with the micronemal protein AMA1 (REFS 140, 141) . Proteins in the bulb of the rhoptry (ROPs) are then released into the host cell cytosol, where they are directed to the host cell nucleus (ROP16 and protein phosphatase 2C (PP2C-hn)) or to the surface of the PV (ROP2, ROP18 and ROP5) 137, 142 . The PV resists acidification and fusion with endosomes and lysosomes, and also recruits host mitochondria and the host ER, both of which might aid in parasite acquisition of nutrients 15 . The extensive modification of the PV during invasion suggests that the parasite modulates many host cell functions as part of its intracellular lifestyle, a prediction that is supported by the genetic studies described in the main text. After several rounds of mitotic division, daughter parasites actively egress from the host cell and invade neighbouring cells. Nature Reviews | Microbiology of glycosylphosphatidylinositol-anchored proteins 46 and TLR11-mediated detection of parasite profilin 47 (FIG. 2) .
However, deletion of individual TLRs has only modest effects on susceptibility to infection, implying that multiple TLRs are involved in the recognition of T. gondii 48 . Consistent with this idea, triple-deficient (3d) mice, which carry a point mutation in the UNC93B1 protein and are defective in TLR3, TLR7 and TLR9 trafficking and in TLR11 signalling, are highly susceptible to infection with T. gondii 49, 50 . IFNγ is the major mediator of resistance to T. gondii and is crucial for the activation of a variety of antimicrobial activities, in both haematopoetic and non-haematopoetic cells, that limit parasite replication 51, 52 (FIG. 2; and see Supplementary information S1 (table) ). For example, IFNγ alters cell metabolism, which can lead to tryptophan degradation in fibroblasts 53 and iron starvation in enter ocytes 54 . This cytokine also stimulates professional phagocytes to produce reactive oxygen and nitrogen intermediates, which can lead to parasite damage and impede growth in macrophages 55, 56 . Studies using inducible nitric oxide synthase (iNOS)-deficient mice have demonstrated the existence of an IFNγ-dependent, iNOS-independent mechanism of resistance to T. gondii, and have shown that this mechanism operates during the acute phase of infection 57 . This pathway relies on immunity-related GTPases (IRGs), which are induced by IFNγ and contribute to clearance of T. gondii in multiple cell types 58, 59 ( FIG. 2; see also see Supplementary information S1 (table)) . Although the precise mechanisms are not understood, recruitment of IRGs to the PV leads to PV vesiculation and rupture, and subsequent digestion of the parasite within the cytosol 60 . A related family of GTPases known as p67 guanylate-binding proteins (GBPs) was recently shown to contribute to control of toxoplasmosis in the mouse 61 . This family of proteins is more widely conserved among vertebrates 62 and is also implicated in the control of Listeria spp. and mycobacteria 63 , consistent with a more general role in host resistance to infection 64 . Although innate immune responses to T. gondii have been examined in detail, how these processes lead to the stimulation of adaptive immunity, including the ability of DCs to access antigens for priming of CD4 + and CD8 + T cells, is less well understood. Within the PV, the parasite is shielded from the major pathways for antigen processing and presentation, as discussed recently 65 . Moreover, infection of host cells is associated with reduced expression of major histocompatibility complex (MHC) molecules 66 . Despite these mechanisms of avoidance, infection with type II strains of T. gondii leads to the activation and expansion of DCs and a strong CD8 + T cell response, whereas infection with virulent type I strains induces a weaker response 67 . Several prominent endogenous parasite antigens are presented on MHC class I molecules, including dense-granule protein 6 (GRA6) 68 , GRA4 and rhoptry protein 7 (ROP7) 69 . These antigens are polymorphic between strains, suggesting that they are involved in strain-dependent evasion mechanisms that also influence adaptive immunity. Other studies have highlighted the importance of highly + and CD8 + T cells as the adaptive response ensues. IL-10 and IL-27 are key to modulating these pathways and prevent the overproduction of T helper 1 type cytokines. c | The production of IFNγ during the innate and adaptive phases is responsible for activating cells to control parasite infection. IFNγ propagates a signal through a surface IFNγ receptor (IFNγR) to activate signal transducer and activator of transcription 1 (STAT1), a nuclear transcription factor that controls the expression of many genes. In response to STAT1 activity, monocytes and macrophages upregulate their production of nitric oxide (NO) and reactive oxygen species (ROS), both of which contribute to the control of intracellular parasites. Both haematopoetic and non-haematopoetic cells upregulate two families of defence proteins called immunity-related GTPases (IRGs) and p67 guanylate-binding proteins (GBPs), which are recruited to the parasitophorous vacuole (PV) and are involved in parasite clearance. The function of IRGs and GBPs depends on autophagy protein 5 (ATG5).
Glycosylphosphatidylinositolanchored proteins
Proteins with a common glycolipid anchor that is covalently attached to the carboxyl terminus as a post-translational modification.
Inducible nitric oxide synthase
(iNOS). A soluble enzyme that produces nitric oxide from l-arginine. This enzyme is upregulated by interferon-γ and tumour necrosis factor, and constitutes a major antimicrobial activity of macrophages. It is encoded by NOS2.
Immunity-related GTPases (IRGs). A family of 45-47 kDa
GTPases that are strongly upregulated by interferon-γ and contribute to resistance to intracellular pathogens. These GTPases are ubiquitous in the mouse, but are more rare in other vertebrates and largely absent in humans.
p67 guanylate-binding proteins (GBPs) . A family of 65 kDa GTPases that are upregulated by interferon-γ and contribute to resistance to intracellular pathogens. These GTPases are widely distributed in vertebrates, indicating that they might have an important general role in resistance to intracellular pathogens.
Major histocompatibility complex
A cell surface molecule that allows recognition of epitopes from foreign or self antigens through presentation of these antigens to T cells.
Signal transducer and activator of transcription 1 (STAT1). One of a family of transcription factors that are activated by Janus kinases (JAKs) and regulate gene expression by binding to nuclear promoters. STATs have a role in development and the immune system.
Nuclear factor-κB
(NF-κB). A complex that controls DNA transcription in response to various signalling inputs and has a key role in regulating innate and adaptive immune responses.
immunogenic surface antigens (SAGs) and SAG-related surface antigens (SRSs) in stimulating the adaptive immune response 70 .
Alterations in host signalling and immune evasion
Many innate immune effectors are under the control of transcription factors that enhance or regulate the overall immune response to invading microorganisms. In turn, successful pathogens have developed strategies to undermine important host cell immune pathways. Infection of mammalian cells with T. gondii induces many changes in the transcription of host cell genes, including those involved in energy metabolism, immune responses and signalling 71 . Here, we focus specifically on how the parasite alters the immune response, as this is crucial for our understanding of how the infection is controlled and, as seen below, the host immune response is a major target of T. gondii virulence factors.
Infection with T. gondii inhibits host cell signalling pathways involved in protective immunity, for example by blocking the transcription factors signal transducer and activator of transcription 1 (STAT1) 72 and nuclear factor-κB (NF-κB) [73] [74] [75] . Fibroblasts that are already infected with any of the three major natural strain types of T. gondii (that is, strain types I, II and III) are unresponsive to the antimicrobial effects of IFNγ, and this appears to be due to defective STAT1 signalling 76 . In T. gondii-infected bone marrow-derived macrophages, this occurs because of modifications in chromatin structure that disrupt STAT1 binding to nuclear promoters 77 . Infection with T. gondii also upregulates anti-inflammatory pathways, including those involving the suppressor of cytokine signalling (SOCS) proteins SOCS1 (REFS 78, 79) and SOCS3 (REF. 80 ), and STAT3 (REF. 81 ), potentially compromising host mechanisms of parasite control.
Although IFNγ promotes antimicrobial activities in many cell types, in macrophages it is not typically sufficient for the control of T. gondii, as a second signal is required to fully activate killing. The best characterized second signals that promote control of T. gondii in vitro are provided by tumour necrosis factor (TNF) and CD40 , both of which use the NF-κB signalling pathway. The NF-κB family of transcription factors has an important role in the immune response to T. gondii -as expected, considering the evolutionarily conserved role for these transcription factors in the regulation of many aspects of innate and adaptive immune functions 85, 86 . Notably, the activation of NF-κB by type II T. gondii strains is associated with higher levels of IL-12 production 36 , an effect that contributes to early control of these infections.
Mapping and identification of virulence loci
Based on the pioneering studies of Elmer Pfefferkorn, who first demonstrated the potential for classical genetics in T. gondii 87 , a number of pairwise genetic crosses were undertaken to map the genetic loci responsible for the major phenotypic differences between the clonal lineages
. These forward-genetics studies have been extremely effective in identifying the underlying genetic basis for some of the most striking phenotypic differences between lineages I, II and III, and notably for the differences in acute virulence and induction of host cell signalling 88 .
Identification of ROP kinases as mediators of acute virulence. During parasite invasion of host cells, secretory organelles in the parasite, known as rhoptries, discharge their contents into the host cell
, making these organelles primary candidates for modulating host signalling 89 . This prediction was confirmed when ROP18 was identified as a major factor that contributes to strainspecific differences in virulence 90, 91 . ROP18 is an active serine/threonine protein kinase that, after secretion into the host cell, decorates the surface of the PV membrane (PVM)
. It is a polymorphic protein, and its expression levels vary between strains, being high in type I and type II strains but low in type III strains. Transgenic expression of ROP18 from type I or type II strains in the type III background greatly enhances virulence of this otherwise-avirulent strain type, confirming that this locus is responsible for the observed differences in virulence between strains 90, 91 . This gain of virulence in type III strains requires an active kinase, as virulence is not enhanced in type III parasites transfected with a ROP18 allele encoding a protein with disrupted kinase activity 90 . The low levels of ROP18 expression in type III strains is attributed to the presence of a unique ~2 kb region upstream of the ROP18 coding sequence; this region is absent in type I and type II strains 92 . A comparison of this region with the same region in the related parasite Neospora caninum suggests that it underwent a re-arrangement in the ancestral progenitor to type I and type II T. gondii strains 92 , leading to upregulation of ROP18 expression and, thus, enhanced virulence of these two lineages. Both virulent and avirulent alleles (encoded by strain types I and II, and by strain type III, respectively) are stable in the population and show evidence of long-term stability 92 , implying that these different variants are adapted for distinct niches.
Genetic crosses between strain types II and III led to the identification of a protein that is responsible for the ability of these strains to differentially affect host gene transcription 93
. This particular ROP kinase, ROP16, is unusual in that it is targeted to the host nucleus 93 . 
. In both studies, genetic disruption of the ROP5 locus in a type I strain led to severe attenuation, which was restored with complementation 94, 95 . The ROP5 locus contains a tandem repeat of 6-10 polymorphic genes that differ between strain types, but are all predicted to encode catalytically inactive pseudokinases 94, 95 . Comparison of the three pairwise crosses predicts that the proteins encoded by ROP5 and ROP18
Suppressor of cytokine signalling (SOCS)
. A family of intracellular proteins that regulate cytokine signalling by either direct inhibition of receptors or increased degradation of signalling proteins.
Tumour necrosis factor
(TNF). A cytokine involved in inflammation, tumour suppression and host defence.
Pseudokinase
A protein that contains a conserved protein kinase fold but lacks key residues in the nucleotide-binding pocket, resulting in an inability to transfer phosphate to a donor substrate. Although these proteins are not catalytically active, they serve regulatory or scaffolding roles.
Quantitative trait locus
(QTL). A genetic region (or locus) that contributes to a quantitative trait (a trait that varies by degree). Such traits are typically polygenic, with multiple QTLs contributing to the phenotype.
Mitogen-activated protein kinases
(MAPKs). Serine/threonine kinases that are involved in cellular signalling in response to a diverse array of stimuli.
Centimorgan
A genetic unit used for establishing genetic linkage based on recombination frequency in the progeny of a genetic cross. 1 centimorgan is equal to the distance over which the average proportion of recombination events in a single generation is 1%. Named in honour of Thomas Hunt Morgan. function together, and these two genes explain nearly 90% of the differences in acute virulence between these three lineages.
The diversity of ROP kinases in T. gondii. Protein kinases are expanded in most eukaryotic lineages, in which they control a number of important signalling pathways; they are defined by a series of conserved domains that fold into common amino-and carboxyterminal lobes 96 . These kinases contain a nucleotidebinding pocket characterized by a number of conserved motifs, including a catalytic triad that transfers γ-phosphate from ATP to an acceptor hydroxyl group on serine, threonine or tyro sine 96 . Pseudokinases encode intact proteins that typically lack the ability to catalyse phosphate transfer, but they can act as scaffolds to regulate enzymatic processes 97 . The realization that rhoptries contain a family of related polymorphic serine/threonine protein kinases and pseudokinases led to a bioinformatic search that identified 44 other ROP kinase family members, of which about half are predicted to be active and the remainder are predicted to be pseudokinases 98 . The ROP kinase family is highly diverse in T. gondii and related apicomplexans, including N. caninum, and the abundance of non-synonymous substitutions in ROP genes, often accompanied by gene duplication, indicates that they are under strong selective pressure 98 . Most of the predicted ROP kinase and pseudokinase family members have not been studied, but several have been validated as bona fide rhoptry proteins that are secreted into the host cell during invasion 98 . For example, ROP38 from type III parasites is implicated in downregulating host mitogen-activated protein kinase (MAPK) signalling, as expression of this protein in a type I background suppresses this pathway 98 . However the precise role of ROP38 in pathogenesis is still uncertain. For the remainder of the Review, we focus on the ROP kinases for which functions have been elucidated. ROP18 and ROP5 belong to a ROP kinase family subset that is typified by the pseudokinase ROP2 (the first member of this family that was predicted to contain a kinase domain) 99 . This prediction was borne out when
Box 2 | Mapping of Toxoplasma gondii virulence loci
Classical genetic crosses between the three main clonal strains of Toxoplasma gondii have been useful for defining the virulence determinants of the parasite. These crosses were conducted by tagging strains with drug resistance markers and feeding cats with a mixture of cysts obtained from mice infected with two different parasite strains, to generate recombinant oocysts in the cat 143 ( see FIG. 1 ). Three pairwise genetic crosses were conducted between the different strains (see the table), and single-cell F1 progeny isolated from the oocysts were used to generate genetic linkage maps 144 and to identify phenotypic traits (as described in more detail previously 23, 143 ). Analysis of these genetic crosses revealed that the genome of T. gondii is approximately 65 × 10 6 bp in size and is organized into 14 linear chromosomes that range in size from 2 Mb to 10 Mb
144
. Recombination rates are fairly low, with 1 centimorgan corresponding to roughly 100 kb 144 . These parameters predict that it should be reasonably easy to map a given trait to a region of one chromosome, but more challenging to fine-map and identify the gene of interest. Additional criteria that are useful in narrowing down the candidate gene list include differential expression levels, high levels of allelic polymorphism and the allocation of genes to specific functional pathways -for example, genes encoding surface or secretory proteins (that is, proteins that might be in contact with the host) might be more likely to contribute to pathogenesis than other genes. Genetic crosses between the three main lineages have been used to analyse the segregation of several traits, including acute virulence 90, 91, 94, 95 , growth 90 , migration potential 90 and effects on host cell transcription 93 . The analysis of complex traits has been facilitated by the use of quantitative trait locus (QTL) mapping, which provides a statistical means of evaluating the contribution of multiple loci to a given phenotype and for examining interactions between these loci 145 . QTL analysis of growth differences between type I (fast growth) and type III (slow growth) strains of T. gondii revealed that four or more major loci control this trait 90 , which might explain why the individual genes responsible for this characteristic -each of which makes only a small contribution to the phenotype -have thus far eluded identification. Likewise, differences in migration potential 90 , which may contribute to virulence 146 , map to a broad region of chromosome VIIa, but have not yet been localized to a specific gene (or genes). Genes that have been identified by mapping, and their known targets, are summarized in the table. (FIG. 3a) . By aligning the sequence of ROP18 to known serine/threonine kinases, all of the conserved residues known to be important in ATP binding and catalysis have been identified 101 . It has also been shown that ROP18 has a novel mechanism of activation that relies on phosphorylation of an N-terminal helical domain which wraps around the N-lobe and inhibits kinase activity when it is unphosphorylated 101 . In contrast to ROP18, the pseudo kinases ROP2 and ROP8 have a highly degenerate nucleotide-binding pocket and are not predicted to bind or hydrolyse ATP 100, 101 . Similarly, ROP5 is predicted to be a pseudokinase: although it is able to bind ATP, it is unlikely to carry out phosphate transfer because of an alteration in the central residue of the catalytic triad (arginine or histidine instead of aspartic acid) 102 . Remarkably, ROP2 kinase family members are highly conserved among T. gondii strains, but amino acid differences between strains are clustered in the substrate-binding loop 101 . This implies that, even though these proteins are not catalytically active, they are capable of binding specific host substrates. ROP2 family members also have an N-terminal extension that contains three amphipathic α-helical regions which are rich in arginine on one face and hydrophobic on the other 103 . This low-complexity N-terminal region is predicted to be involved in mediating membrane interactions and has been shown to be necessary and sufficient for targeting to the PVM 103,104 (FIG. 3b,c) . As recently shown, ROP18 targeting to the PVM determines the access of this kinase to host substrates and is essential for virulence 105 . 
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Host targets affected by T. gondii secretory proteins
T. gondii
Degradation
Arginase
An enzyme that mediates the consumption of arginine in the urea cycle and thus has an antagonistic role to nitric oxide synthase, as they both rely on the same substrate.
Alternatively activated macrophages
Macrophages that have a T helper 2 type phenotype, dampening inflammation and promoting repair; these cells also typically express arginase. This is one of two polar phenotypes that macrophages can adopt following stimulation by cytokines.
downregulates the induction of IL-12, thus limiting protective T helper 1 (T H 1) type cytokine responses 93 ; this might lead to less inflammation and reduced pathology, but also to enhanced parasite survival (FIG. 4) . Consistent with this model, transgenic expression of a ROP16 I allele in type II strains inhibits IL-12 production 93 , whereas the Δrop16 type I strain induces increased IL-12 production, and also triggers the release of TNF following stimulation of infected cells with lipopolysaccharide (LPS) 108 . Despite having profound effects on host gene expression, ROP16 has only a moderate role in acute virulence in mice. Deletion of ROP16 in a type I strain does not reduce host mortality following intraperitoneal challenge, and in fact the mutant shows slightly enhanced growth in vivo compared with a wild-type type I strain 108 . ROP16 might also have a role in reducing inflammation and thus could have important roles in other infection models, as transgenic expression of ROP16 I/III in a type II strain reduces the pathology caused by oral infection of mice 109 . The enhanced growth that is observed in the absence of ROP16 might be explained by the ability of this protein to activate STAT6, which leads to the induction of arginase, an enzyme associated with alternatively activated macrophages 108 . It is possible that arginase has two opposing roles in T. gondii growth: providing polyamines and thus enhancing parasite growth, but limiting access to the essential amino acid arginine and thus impairing growth 110 . The induction of arginase is also expected to antagonize the ability of macrophages to kill intracellular parasites, as arginine also serves as a substrate for iNOS; consistent with this, elimination of arginase in macrophages promotes resistance to T. gondii 111 . Thus, the balance of these two opposing roles for arginase might determine whether the pathogen persists or is eliminated in vivo.
Induction of IL-12 production by GRA15. Infection of macrophages with type II parasites results in the production of higher levels of IL-12 than infection with the other two lineages 36 . This effect is partly modulated by ROP16, as the ROP16 II allele expressed in type II strains is incapable of sustained phosphorylation of STAT3 and STAT6, as discussed above. However, this is unlikely to be the sole factor responsible for the increased levels of IL-12 during infection with type II strains. Indeed, genetic mapping identified a locus on chromosome X encoding a dense-granule protein, named GRA15, that is responsible for the induction of IL-12 in type II strains (FIG. 4) , and expression of the type II GRA15 variant (GRA15 II ) in a type I strain enhances IL-12 production 112 . The molecular mechanism of this GRA15 function is uncertain, as the protein has no homology to any other proteins in the available databases and does not contain any conserved domains.
Localization studies revealed that GRA15 is secreted into the host cell together with ROP proteins in small cytoplasmic inclusions known as evacuoles 112 . GRA15 also localizes to the PVM 112 , although its topology at this interface has not been established. Deletion of GRA15 in the type II strain T. gondii ME49 prevents nuclear translocation of NF-κB, but the mechanism by which GRA15 activates NF-κB is incompletely understood. However, this mechanism is known to be independent of MYD88, proteins of the IL-1 receptor (IL-1R) family and TIR domain-containing adaptor inducing interferon-β (TRIF; also known as TICAM1) 112 . As MYD88 and TRIF coordinate the main signalling pathways for TLR ligands, it seems unlikely that GRA15 is recognized by a TLR. Nonetheless, the induction of NF-κB by GRA15 depends on TNF receptor-associated factor 6 (TRAF6), which is an adaptor that functions with IL-1R-associated kinase 1 (IRAK1) to mediate signalling downstream of MYD88. Engagement of TRAF6 activates the IκB kinase (IKK) complex, which triggers the phosphorylation and subsequent degradation of inhibitor of NF-κB (IκB) and thus leads to translocation of NF-κB to the nucleus 112 (FIG. 4) . GRA15 appears to be sufficient to induce this pathway, as GRA15 expression in HeLa cells results in nuclear translocation of NF-κB 112 . Although GRA15 II can directly drive NF-κB A dense-granule protein of type II parasite strains, GRA15 II , activates tumour necrosis factor receptor-associated factor 6 (TRAF6), which in turn activates IκB kinase (IKK), leading to the phosphorylation and proteasomal degradation of inhibitor of NF-κB (IκB) and the consequent release of nuclear factor-κB (NF-κB). NF-κB migrates to the host nucleus (dashed arrow) and drives the production of IL-12. Another parasite protein, ROP18, is localized on the cytoplasmic side of the parasitophorous vacuole (PV). ROP18 I has been shown to phosphorylate immunity-related GTPases (IRGs), thus blocking their accumulation on the PV membrane and protecting the parasite from destruction. ROP18 I also phosphorylates the host protein ATF6β (activating transcription factor 6β), which is involved in the unfolded-protein response and might also be important for efficient antigen presentation by dendritic cells. Phosphorylated ATF6β is trafficked to the proteasome, where it is degraded. Genetic and biochemical evidence suggests that ROP5 I/III , a pseudokinase that is important for virulence, regulates the functions of ROP18 I .
TIR domain-containing adaptor inducing interferon-β (TRIF). An adaptor protein for signalling from Toll-like receptors, which also contain TIR domains.
TNF receptor-associated factor 6 (TRAF6). A protein adaptor that is involved in signalling through tumour necrosis factor (TNF), interleukin-1 and Toll-like receptors.
IκB kinase
(IKK). A kinase comprising two catalytic subunits, IKKα and IKKβ, and a regulatory subunit, IKKγ (also known as NEMO). IKK targets inhibitor of NF-κB (IκB) to induce its degradation, allowing nuclear factor-κB (NF-κB) to translocate to the nucleus. Modulation of acute virulence by ROP18 and ROP5. As noted above, differences in virulence between strains of T. gondii are associated with the serine/threonine kinase ROP18 and the related pseudokinase ROP5. Understanding the mechanistic basis for this effect has been aided by the recent observation that this pair of parasite effectors targets host immunity by disrupting the function of host IRGs (FIG. 4) . Induced by IFNγ, ΙRGs are crucial for the control of toxoplasmosis in mice 59, 60 . This family of enzymes is expanded in the mouse system but has fewer members in other vertebrates (for example, humans have only two IRGs) 115 . Although the PVM lacks most host cell proteins 15 , IRGs are recruited to the PVM that surrounds type II and type III T. gondii strains, where these proteins cause vesiculation and promote parasite destruction 116, 117 (a process that is also dependent on the autophagy protein ATG5, although the nature of the involvement of ATG5 is unclear 118 ). Unlike strain types II and III, highly virulent type I strains avoid this fate by blocking IRG recruitment 116, 119 . In IFNγ-activated cells, several IRGs, including Irga6 (also known as IIGP1), Irgb6 (also known as TGTP and GTP2) and Irgb10, are phosphorylated by ROP18 I , and this phosphorylation is associated with reduced IRG recruitment to the PVM 120, 121 (FIG. 4) . Transgenic expression of the active form of ROP18 I in a type III parasite inhibits IRG recruitment to the PVM, resulting in persistence of the parasite in activated macrophages 120 . RNAimediated suppression of Irgb6 in mouse macrophages reverses the enhanced clearance of type I parasites lacking ROP18 I (REF. 120 ). Details of the interplay between ROP18 I and IRGs were revealed by mass spectrometry, which showed that ROP18 I phosphorylates key threonine residues in switch region I of Irga6 and Irgb6 (REFS 120, 121) . Phosphorylation of Irga6 prevents the GTP-hydrolysing activity and oligomerization of this protein 121 , steps that are thought to be important for the loading of IRGs onto the PVM 122 . These findings indicate that ROP18 I contributes to virulence by prolonging the survival of T. gondii in IFNγ-activated macrophages. Moreover, the role of ROP18 I in blocking IRG function is not limited to professional phagocytes, as similar studies have shown that it is important for the avoidance of IRG recruitment to the PVM in activated fibroblasts 121 . More recently, activating transcription factor 6β (ATF6β), which resides in the host ER and is important in the unfolded-protein response, was identified as a ROP18 I target 123 (FIG. 4) . In cells co-transfected with ROP18 I and ATF6β, phosphorylation of ATF6β by ROP18 I leads to proteasomal degradation of ATF6β and to a consequent reduction in ATF6β-mediated gene expression when the unfolded protein response is induced 123 . The interaction of ROP18 I with ATF6β in co-transfected cells has been mapped to the N terminus of the ROP kinase and the C terminus of ATF6β 123 . As the C terminus of ATF6β is in the lumen of the host ER, whereas the N terminus of ROP18 I is tethered to the PVM, this interaction suggests a precise topological rearrangement of one or both of these proteins within infected cells. A role for ATF6β in vivo has been shown by the increased susceptibility of Atf6b-knockout mice to challenge with an attenuated Δrop18 type I T. gondii strain. Moreover, CD8 + T cells incubated with DCs from Atf6b-knockout mice have a reduced ability to induce IFNγ production 123 , suggesting that ATF6β has a previously unrecognized role in antigen presentation.
Inhibitor of NF-κB
Although the Δrop18 type I parasite is highly attenuated in IFNγ-activated macrophages in vitro, this mutant is only partially attenuated in vivo 120 . By contrast, deletion of the pseudokinase ROP5 in the type I background significantly decreases in vivo virulence by more than one-million-fold 94, 95 . However, because the ROP5 locus encodes a tandem array of predicted pseudokinases, it was initially unclear why the catalytically inactive ROP5 protein would have such a dramatic effect on virulence. Insights into this question have been provided by biochemical studies suggesting that ROP5 and ROP18 interact. First, it has been established that the major variant of ROP5 in type I strains binds to Irga6 and affects its ability to form GTP-dependent oligomers in vitro 124, 125 , which is likely to decrease Irag6 loading onto the T. gondii-containing vacuole in infected cells. In two separate studies, it has been shown that the major type I ROP5 variant enhances ROP18 I -mediated phosphorylation of Irga6 (REF. 124 ) and Irgb6 (REF. 126 ). As this ROP5 variant does not bind well to Irgb6, this effect of ROP5 is likely to be due to enhanced catalytic activity of ROP18 I (FIG. 4) -a hypothesis that has been confirmed by in vitro studies 126 . This finding indicates that in type I strains ROP5 allosterically activates ROP18 I , as has been recently described for several human kinases 97, 127 . Collectively, these data suggest a model in which ROP5 of type I strains contributes to acute virulence in the mouse by activating other ROP kinases, as well as by disrupting IRG oligomerization, thus allowing type I T. gondii strains to evade antimicrobial effector mechanisms. Although type II strains contain a form of ROP18 that is capable of enhancing virulence when combined with the type I and type III forms of ROP5, it does not appear able to do so in the context of the type II forms of ROP5. The precise reasons for this are unknown but might involve differences in the capacity of ROP5 variants to bind to IRGs or to directly activate ROP18.
Strain-dependent T. gondii virulence in mice
Genetic mapping studies have revealed that the marked phenotypic differences between strains of T. gondii in mice are mediated by combinations of different alleles at only a few major loci. The acutely virulent type I strains have high levels of ROP18, which in these strains functions cooperatively with the major variant of type I ROP5 to phosphorylate host IRGs, inhibit IRG loading on the PVM and subsequently block parasite clearance in IFNγ-activated cells (FIG. 4; TABLE 1 ). ROP18 also targets ATF6β and might thus compromise antigen presentation by DCs. Type I parasite strains also express ROP16 variants that induce long-term activation of STAT3 and STAT6, and so can dampen T H 1 type cytokine responses, and a GRA15 variant that fails to induce the pro-inflammatory cytokine IL-12 (FIG. 4; TABLE 1 ). The combined activities of these effectors could allow the parasite to delay the induction of protective immunity systemically while escaping the innate mechanisms of control that occur within infected cells, ultimately resulting in parasite expansion to high tissue burdens. Somewhat paradoxically, mice eventually succumb to infection with type I T. gondii strains, despite producing high levels of type 1 cytokines 128, 129 . It is likely that the initial impairment of T H 1 type responses (via ROP16, ROP18 and possibly other factors) allows parasite expansion and results in a high parasite burden that causes tissue damage and subsequent activation of danger signals, triggering a secondary response that leads to cytokine-mediated pathology. Although the molecular basis of this strong acute-virulence trait is not fully understood, the trait is also shared by numerous South American lineages 92 . Despite this phenotype leading to rapid death of laboratory mice, it might be an adaptation enabling the parasite to survive in hosts such as wild deer mice 130 , rats 131 and chickens 132 , all of which appear to be innately resistant to infection. In contrast to the extreme virulence of type I strains, type II strains induce protective immunity and exhibit intermediate virulence. Despite having a virulence-enhancing ROP18 variant, they express a ROP5 variant that is avirulent (FIG. 4; TABLE 1 ). Consequently, they are less able to avoid IRG-mediated clearance within IFNγ-activated cells (FIG. 4; TABLE 1) . Furthermore, the GRA15 II variant induces the production of IL-12, and the inability of this strain to prolong STAT3 and STAT6 activation (owing to the particular ROP16 variant that it encodes) results in early IL-12 production, leading to a type 1 cytokine response and effective control of acute infection (FIG. 4; TABLE 1 ). Such a strategy is consistent with the high propensity of type II strains to differentiate into bradyzoites, and with the associated prevalence of these strains in chronic infections in animals. Finally, type III strains appear to lack an effective mechanism for blocking IRGs because they underexpress ROP18 by ~100-fold compared to the levels in type I and type II strains (FIG. 4; TABLE 1) . As a result, they are readily cleared from IFNγ-activated mouse macrophages. Type III strains also induce prolonged phosphorylation of STAT3 and STAT6 and do not strongly activate NF-κB, so they avoid inducing IL-12 (FIG. 4; TABLE 1 ). This strategy might be an adaptation to allow these strains to survive in hosts that lack the IRG pathway or in which overproduction of cytokines causes detrimental pathology. Although we do not know which specific hosts each of these phenotypes are adapted for, they are each common in natural isolates and thus reflect successful long-term evolutionary strategies 92 .
Future directions
Recent advances have revealed that, like other pathogens that inject virulence factors into host cells [133] [134] [135] , T. gondii injects ROP proteins not only into the cells that it infects but also into bystander cells 136 . Using this so called 'kiss and spit' model 137 , the parasite can modify the cell that it resides in, and can also potentially influence the behaviour of adjacent cells 136 . An assessment of the many characterized mutants with advanced imaging techniques should allow further molecular dissection of the interactions between the parasite and its host in order to reveal the strategies that are central to T. gondii dissemination and pathogenesis. The questions that have received the most focus in the past decade have revolved around understanding the differences in virulence between parasite strains and have provided important new perspectives on pathogenesis in the mouse model. Extending these studies to other host species will be crucial if we are to evaluate the contribution of virulence factors to transmission dynamics and disease in natural hosts. Beyond the traits described here, many other differences in host responses have been noted in previous studies, although most of these have not been examined for potential parasite strain-specific or host differences (see Supplementary   information S2 (table) ). Thus far, most studies have focused on only the dominant strains in North America and Europe. The application of these approaches to more diverse lineages from South America and other regions 24 is likely to reveal additional layers of complexity in parasite virulence. Moreover, the current strategy for mapping genetic differences is unlikely to uncover conserved mechanisms used by all strains of T. gondii to evade the immune response. Additional forward-genetics screens will be needed to identify the molecular basis of such virulence activities. As additional, more powerful experimental approaches are developed, we can look forward to learning more about the role of parasite secretory proteins in modulating host functions.
